Advertisement
cbdMD, Inc.

cbdMD, Inc. (YCBD) Stock Overview

Explore cbdMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

YCBDAMEX
HealthcareDrug Manufacturers - Specialty & Generic
$0.70
$0.008(1.12%)
U.S. Market opens in 54h 49m
Advertisement

cbdMD, Inc. (YCBD)

Meyka AI Score

Z

Key Financials

Market Cap7.3M
P/E Ratio-1.71
EPS (TTM)$-0.41
ROE-0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$0.78
3 Months$0.98
1 Year Target$0.00

YCBD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of cbdMD, Inc. (YCBD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.71 and a market capitalization of 7.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.12%
5-Day Change
-0.47%
1-Month Change
-8.54%
3-Month Change
-8.19%
6-Month Change
-58.63%
Year-to-Date (YTD) Change
-48.51%
1-Year Change
-20.47%
3-Year Change
-94.36%
5-Year Change
-99.94%
All-Time (Max) Change
-99.97%

Contact Information

704 445 3060
8845 Red Oak Boulevard, Charlotte, NC, 28217

Company Facts

420 Employees
IPO DateNov 17, 2017
CountryUS
Actively Trading

Frequently Asked Questions